Axcella Health Stock Price, News & Analysis (NASDAQ:AXLA)

Axcella Health trades on the NASDAQ under the ticker symbol "AXLA."

Axcella Health Inc (NASDAQ:AXLA) released its earnings results on Monday, August, 12th. The company reported ($0.95) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.65) by $0.31. View Axcella Health's Earnings History.

Axcella Health is scheduled to release their next quarterly earnings announcement on Monday, November 11th 2019. View Earnings Estimates for Axcella Health.

4 brokerages have issued 12-month price targets for Axcella Health's stock. Their forecasts range from $20.00 to $25.00. On average, they expect Axcella Health's share price to reach $22.00 in the next twelve months. This suggests a possible upside of 319.0% from the stock's current price. View Analyst Price Targets for Axcella Health.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Axcella Health in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Axcella Health.

News coverage about AXLA stock has been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Axcella Health earned a news impact score of 2.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for Axcella Health.

Axcella Health saw a drop in short interest in the month of September. As of September 30th, there was short interest totalling 40,000 shares, a drop of 7.6% from the August 30th total of 43,300 shares. Based on an average trading volume of 12,300 shares, the short-interest ratio is currently 3.3 days. Currently, 0.5% of the shares of the stock are short sold. View Axcella Health's Current Options Chain.

Some companies that are related to Axcella Health include Replimune Group (REPL), Adverum Biotechnologies (ADVM), DBV TECHNOLOGIE/S (DBVT), Cellectis (CLLS), Translate Bio (TBIO), Prevail Therapeutics (PRVL), Tcr2 Therapeutics (TCRR), Agenus (AGEN), CASI Pharmaceuticals (CASI), Avrobio (AVRO), Precision BioSciences (DTIL), Harpoon Therapeutics (HARP), Gritstone Oncology (GRTS), Cellular Biomedicine Group (CBMG) and ADMA Biologics (ADMA).

Based on aggregate information from My MarketBeat watchlists, some companies that other Axcella Health investors own include Triton International (TRTN), Main Street Capital (MAIN), Achillion Pharmaceuticals (ACHN), Adobe (ADBE), Blackline (BL), Coda Octopus Group (CODA), Exelixis (EXEL), Stamps.com (STMP), Xilinx (XLNX) and Delek US (DK).

(AXLA) raised $76 million in an initial public offering (IPO) on Thursday, May 9th 2019. The company issued 3,600,000 shares at a price of $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink served as the underwriters for the IPO.

Axcella Health's lock-up period expires on Tuesday, November 5th. Axcella Health had issued 3,571,428 shares in its IPO on May 9th. The total size of the offering was $71,428,560 based on an initial share price of $20.00. After the expiration of the company's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.

Shares of AXLA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of AXLA stock can currently be purchased for approximately $5.25.

Axcella Health has a market capitalization of $121.17 million. View Additional Information About Axcella Health.

The official website for Axcella Health is http://www.axcellahealth.com/.

Axcella Health's mailing address is 840 MEMORIAL DRIVE, CAMBRIDGE MA, 02139. The company can be reached via phone at 857-320-2200.